Skip to main content

Leading Drugmakers Respond to Omicron Variant: Latest From Merck, Regeneron

Publish date:
Video Rating:
Video Duration:

Drugmakers Regeneron  (REGN) - Get Regeneron Pharmaceuticals, Inc. Report and Merck  (MRK) - Get Merck & Co., Inc. Report are preparing for the newest challenge in the Covid-19 pandemic, the omicron variant.

The variant has spread to at least 19 nations around the world, but the actual level of the threat omicron presents has yet to be established. 

Vaccine makers are cautiously casting doubt on the effectiveness of the existing vaccines on the new variant because of the more than 30 mutations to its spike protein, though further data is needed. 

Watch the video above for the latest news from Merck and Regeneron. 

Related Videos